MedicaidCoverageMedium impact

Updated Coverage of Brixadi for Opioid Use Disorders

Q: Who is affected by this change?

This affects Maryland Medicaid Psychiatry, Family Medicine, Internal Medicine, Pain Management providers in MD on Medicaid plans.

Maryland Medicaid·MD · Psychiatry, Family Medicine, Internal Medicine +1 more·Behavioral Health Administration Services Organization

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

Maryland Medicaid has updated coverage policies for Brixadi, a medication used to treat opioid use disorders. This affects billing and coverage determination for substance abuse treatment providers serving Maryland Medicaid patients.

Action Required

Action needed

Immediately: Review the full Maryland Medicaid transmittal PT 66-25 for specific coverage criteria and billing requirements for Brixadi. Update prior authorization processes and coverage verification procedures for opioid use disorder treatments. Contact Maryland Medicaid for clarification on new coverage parameters if treating patients with substance use disorders.

Related policy hubs

Maryland Medicaid policies MD policy changes Psychiatry Family Medicine Internal Medicine Pain Management